FDA Approves Wegovy for MASH Treatment in Adults with Moderate to Advanced Fibrosis Regulatory approval for expanded medication indications highlights ongoing efforts to address unmet medical needs in chronic liver diseases. Such pharmaceutical developments illustrate the role of... Adults Right to health Well-being Aug 19, 2025